Literature DB >> 27000321

Care-Delivery Interventions to Manage Agitation and Aggression in Dementia Nursing Home and Assisted Living Residents: A Systematic Review and Meta-analysis.

Eric Jutkowitz1,2, Michelle Brasure1,2,3, Erika Fuchs1,2,4, Tetyana Shippee1, Rosalie A Kane1, Howard A Fink2,3, Mary Butler1,2, Tonye Sylvanus1, Robert L Kane1,2.   

Abstract

OBJECTIVES: To evaluate the efficacy of nonpharmacological care-delivery interventions (staff training, care-delivery models, changes to the environment) to reduce and manage agitation and aggression in nursing home and assisted living residents.
DESIGN: Three bibliographic databases, references of systematic reviews, ClincalTrials.gov, and the International Controlled Trials Registry Platform were systematically searched for randomized controlled trials reporting behavioral outcomes for nonpharmacological care-delivery interventions in nursing homes and assisted living facilities. Five investigators independently assessed study eligibility, extracted data, rated risk of bias, and graded strength of evidence. Inclusion was limited to studies with low to moderate risk of bias.
SETTING: Nursing homes and assisted living facilities. PARTICIPANTS: Facility caregiving staff. MEASUREMENTS: Agitation, aggression, antipsychotic and other psychotropic use, general behavior.
RESULTS: Nineteen unique studies met entry criteria, addressing several categories of facility caregiver training interventions: dementia care mapping (DCM; n = 3), person-centered care (PCC; n = 3), clinical protocols to reduce the use of antipsychotic and other psychotropic drugs (n = 3), and emotion-oriented care (n = 2). Eleven additional studies evaluated other unique interventions. Results were pooled for the effect of each type of intervention on agitation and aggression: DCM (standardized mean difference -0.12, 95% confidence interval (CI) = -0.66 to 0.42), PCC (standardized mean difference -0.15, 95% CI = -0.67 to 0.38), and protocols to reduce antipsychotic and other psychotropic use (Cohen-Mansfield Agitation Inventory mean difference -4.5, 95% C = -38.84 to 29.93). Strength of evidence was generally insufficient to draw conclusions regarding efficacy or comparative effectiveness.
CONCLUSION: Evidence was insufficient regarding the efficacy of nonpharmacological care-delivery interventions to reduce agitation or aggression in nursing home and assisted living facility residents with dementia.
© 2016, Copyright the Authors Journal compilation © 2016, The American Geriatrics Society.

Entities:  

Keywords:  behavioral symptoms; dementia; nonpharmacological; nursing homes; psychosocial interventions

Mesh:

Year:  2016        PMID: 27000321     DOI: 10.1111/jgs.13936

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  25 in total

1.  Individualized Music Program is Associated with Improved Outcomes for U.S. Nursing Home Residents with Dementia.

Authors:  Kali S Thomas; Rosa Baier; Cyrus Kosar; Jessica Ogarek; Alissa Trepman; Vincent Mor
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-14       Impact factor: 4.105

2.  Effects of cognition, function, and behavioral and psychological symptoms on out-of-pocket medical and nursing home expenditures and time spent caregiving for persons with dementia.

Authors:  Eric Jutkowitz; Karen M Kuntz; Bryan Dowd; Joseph E Gaugler; Richard F MacLehose; Robert L Kane
Journal:  Alzheimers Dement       Date:  2017-02-01       Impact factor: 21.566

3.  Pragmatic Trials and Improving Long-Term Care: Recommendations From a National Institutes of Health Conference.

Authors:  Sheryl Zimmerman; Barbara Resnick; Joseph Ouslander; Cari Levy; Joseph E Gaugler; Philip D Sloane; Vincent Mor
Journal:  J Am Geriatr Soc       Date:  2022-02-23       Impact factor: 5.562

4.  Pragmatic trials and improving long-term care: Recommendations from a national institutes of health conference.

Authors:  Sheryl Zimmerman; Barbara Resnick; Joseph Ouslander; Cari Levy; Joseph E Gaugler; Philip D Sloane; Vincent Mor
Journal:  Geriatr Nurs       Date:  2022-02-24       Impact factor: 2.361

5.  Pragmatic Trials and Improving Long-Term Care: Recommendations From a National Institutes of Health Conference.

Authors:  Sheryl Zimmerman; Barbara Resnick; Joseph Ouslander; Cari Levy; Joseph E Gaugler; Philip D Sloane; Vincent Mor
Journal:  J Am Med Dir Assoc       Date:  2022-03       Impact factor: 4.669

Review 6.  Interventions for preventing and reducing the use of physical restraints of older people in general hospital settings.

Authors:  Jens Abraham; Julian Hirt; Christin Richter; Sascha Köpke; Gabriele Meyer; Ralph Möhler
Journal:  Cochrane Database Syst Rev       Date:  2022-08-25

7.  Reducing neuropsychiatric symptoms in persons with dementia and associated burden in family caregivers using tailored activities: Design and methods of a randomized clinical trial.

Authors:  Laura N Gitlin; Catherine Verrier Piersol; Nancy Hodgson; Katherine Marx; David L Roth; Deidre Johnston; Quincy Samus; Laura Pizzi; Eric Jutkowitz; Constantine G Lyketsos
Journal:  Contemp Clin Trials       Date:  2016-06-21       Impact factor: 2.226

8.  Evidence-based Non-pharmacologic Interventions for Managing Neuropsychiatric Symptoms and Mental Health Issues in Residents in Assisted Living.

Authors:  Katherine A Marx; Naomi Duffort; Daniel L Scerpella; Quincy Miles Samus; Laura N Gitlin
Journal:  Seniors Hous Care J       Date:  2017

9.  Connecting policy to licensed assisted living communities, introducing health services regulatory analysis.

Authors:  Lindsey Smith; Paula Carder; Taylor Bucy; Jaclyn Winfree; Joan F Brazier; Brian Kaskie; Kali S Thomas
Journal:  Health Serv Res       Date:  2021-01-10       Impact factor: 3.734

10.  Disseminating START: training clinical psychologists and admiral nurses as trainers in a psychosocial intervention for carers of people with dementia's depressive and anxiety symptoms.

Authors:  Kathryn Lord; Penny Rapaport; Claudia Cooper; Gill Livingston
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.